Analysis | Ref interval | Patient, at 24 months | Unit |
---|---|---|---|
Platelets | 150–350 | 456 | × 109 /L |
Eosinophils | 0.04–0.4 | 0.67 | × 109 cells/L |
IgG | 3.5–10.5 | 15 | g/L |
IgA | 0.07–0.55 | 3.0 | g/L |
IgM | 0.27–1.2 | 1.7 | g/L |
IgE | < 13 | 12,000 | kU/L |
TREC (T-cell receptor excision circles) | > 1500 | 1020 | molecules/million cells |
In vitro T cell proliferation (PHA, ConA, PPD, candida) | All low | % of donors | |
FASCIA (T cell recall response, PHA, PWM, PPD, TT, candida, influenza, CMV, HSV, VZV) | All low for both CD4 + and CD8 + | % of donors | |
Anti TSH receptor ab | + | ||
Anti TPO ab | + | ||
Absolute lymphocyte number | 1.7–6.9 | 0.94 | × 109 cells/L |
CD3+cells T cells | 0.9–4.5 | 0.60 | × 109 cells/L |
CD3+CD4+ | 0.62–0.86 | 0.39 | × 109 cells/L |
CD3+CD4+CCR7+45RA+ Naïve CD4+T cells | 0.26–0.38 | 0.05 | × 109 cells/L |
CD3+CD4+CCR7+45RA+CD31+ CD4+ Recent thymic emigrants | 0.12–0.24 | 0.03 | × 109 cells/L |
CD3+CD4+CCR7+45RA− Central memory CD4+ T cells | 0.20–0.34 | 0.13 | × 109 cells/L |
CD3+CD4+CCR7+45RA−CD38+HLA-DR+ Activated central memory CD4+ T cells | 0–1 | 4 | × 109 cells/L |
CD3+CD4+CCR7−45RA−CD38+HLA-DR+ Activated effector memory CD4+ T cells | 0–0.01 | 0.05 | × 109 cells/L |
CD3+CD4+CCR7+45RA−CXCR3−CCR6+ TH17 cells | 0.06–0.10 | 0.02 | × 109 cells/L |
CD3+CD4+CCR4+CD25hiCD127low45RO− Naïve Treg | 0.02–0.02 | < 0.01 | × 109 cells/L |
CD3+CD8+ | 0.25–0.49 | 0.18 | × 109 cells/L |
CD3+CD8+CCR7+45RA+ Naïve CD8+ T cells | 0.07–0.13 | < 0.01 | × 109 cells/L |
CD3+CD8+CCR7+45RA− Central memory CD8+ T cells | 0.03–0.05 | < 0.01 | × 109 cells/L |
CD3+CD8+CCR7−45RA−CD38+HLADR+ Activated effector memory CD8+ T cells | 0–0.01 | 0.05 | × 109 cells/L |